152 related articles for article (PubMed ID: 19301150)
1. Hairy cell leukemia-related disorders consistently show low CD27 expression.
Hashimoto Y; Tsukamoto N; Nakahashi H; Yokohama A; Saitoh T; Handa H; Matsushima T; Murakami H; Nojima Y; Karasawa M
Pathol Oncol Res; 2009 Dec; 15(4):615-21. PubMed ID: 19301150
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant.
Machii T; Yamaguchi M; Inoue R; Tokumine Y; Kuratsune H; Nagai H; Fukuda S; Furuyama K; Yamada O; Yahata Y; Kitani T
Blood; 1997 Mar; 89(6):2008-14. PubMed ID: 9058722
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin-6 in a patient with polyclonal hairy B-cell lymphoproliferative disorder: a case report.
Okamoto A; Inaba T; Fujita N
Lab Hematol; 2007; 13(4):124-7. PubMed ID: 18192143
[TBL] [Abstract][Full Text] [Related]
4. CD27-positive hairy cell leukemia-Japanese variant.
Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
[TBL] [Abstract][Full Text] [Related]
5. Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review.
Ito M; Harada T; Lang L; Saga T; Kanagawa M; Matsuda R; Yashiro S; Kano S; Sasaki Y; Nakamine H
Int J Surg Pathol; 2022 Oct; 30(7):828-838. PubMed ID: 35234079
[TBL] [Abstract][Full Text] [Related]
6. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
[TBL] [Abstract][Full Text] [Related]
7. PRAME expression in hairy cell leukemia.
Arons E; Suntum T; Margulies I; Yuan C; Stetler-Stevenson M; Kreitman RJ
Leuk Res; 2008 Sep; 32(9):1400-6. PubMed ID: 18295331
[TBL] [Abstract][Full Text] [Related]
8. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
[TBL] [Abstract][Full Text] [Related]
9. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic study of 15 splenectomy specimens of patients with hairy cell leukemia].
Li ZQ; Chen HS; Liu EB; Sun Q; Fang LH; Sun FJ; Zhang PH; Yang QY; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):769-73. PubMed ID: 20079018
[TBL] [Abstract][Full Text] [Related]
11. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
12. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.
Pillai V; Pozdnyakova O; Charest K; Li B; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2013 Oct; 140(4):536-43. PubMed ID: 24045551
[TBL] [Abstract][Full Text] [Related]
13. Absence of surface CD27 distinguishes hairy cell leukemia from other leukemic B-cell malignancies.
Forconi F; Raspadori D; Lenoci M; Lauria F
Haematologica; 2005 Feb; 90(2):266-8. PubMed ID: 15710587
[TBL] [Abstract][Full Text] [Related]
14. [Interferon-alpha therapy for hairy cell leukemia and lymphoproliferative disorders simulating hairy cell leukemia (hairy cell leukemia variant): a cooperative group study in Japan].
Machii T; Kitani T; Kimura K; Maekawa I; Matsuzaki M; Mikuni C; Niikawa K; Igarashi T; Abe T; Miura Y
Rinsho Ketsueki; 1988 Nov; 29(11):2029-36. PubMed ID: 3070073
[No Abstract] [Full Text] [Related]
15. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
16. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the cellular proteins of hairy cell leukemia and the leukemic phase of other lymphoproliferative diseases.
Golomb HM; Nathans AH; Dawson G
Cancer Res; 1980 Jun; 40(6):1907-14. PubMed ID: 7371024
[TBL] [Abstract][Full Text] [Related]
18. Hairy B-Cell Lymphoproliferative Disorder and its Differential Diagnosis: a Case with Long-Term Follow-Up.
Matsuda K; Matsumoto Y; Yoshida M; Shimura K; Kaneko H; Inaba T; Horiike S; Kuroda J; Taniwaki M
Mediterr J Hematol Infect Dis; 2017; 9(1):e2017054. PubMed ID: 28894563
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.
Morgan EA; Yu H; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2013 Feb; 139(2):220-30. PubMed ID: 23355207
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
